Ellen J. Scherl MD AGAF,FACG,FACP,FASGE
Director, Jill Roberts Center for Inflammatory Bowel Disease at New York Presbyterian Hospital/Weill Cornell Medical Center
Jill Roberts Center for Inflammatory Bowel Disease Director of Research
Associate Professor of Clinical Medicine New York Presbyterian Hospital
Jill Roberts Professor of Inflammatory Bowel Disease, Weill Medical College of Cornell University
Adjunct Associate Professor of Medicine at Columbia
University College of Physicians and Surgeons

Ellen J. Scherl, M.D. is the Director of The Roberts Center for Inflammatory Bowel Disease, The Jill Roberts Associate Professor of Clinical Medicine, Sanford I. Weill College of Cornell University - New York Presbyterian Hospital. She is currently an Associated Attending Physician at the New York Presbyterian Hospital-Weill Medical College of Cornell University. She is board certified in internal medicine and gastroenterology.

Dr. Scherl is a world-renowned expert in Inflammatory Bowel Disease specializing in Crohn's Disease and Ulcerative Colitis. Dr. Brian Bosworth and Dr. Vinita Jacob are also part of The Roberts Inflammatory Bowel Disease Center and work closely with Dr. Scherl. Dr. Scherl has an active practice and serves as a principal investigator on many clinical trials on Crohn's Disease and Ulcerative Colitis. As part of Dr. Scherl's comprehensive approach to patient care, she closely collaborates with world renowned IBD surgical team lead by experts Dr. Fabrizio Michelassi and Dr. Jeffrey Milsom, complimented by Dr. Toyoki Sonoda, and Dr. Sang Lee. The team is known for innovative surgical approaches including laproscopic and endoscopic techniques as well as bowel sparing surgeries. The IBD center also works closely with Dr. Robbyn Sockolow, the director of the Pediatric Gastroenterology Division and who also has an active pediatric IBD practice. Dr. Arun Swaminath, and Dr. Oscar Lebwohl of The New York Presbyterian Hospital - Columbia Campus also work closely with Dr. Scherl in her efforts.

Jill Roberts Center for Inflammatory Bowel Disease

Under the directorship of Dr. Ellen Scherl, The Jill Roberts Center for Inflammatory Bowel Disease is a patient-centered medical/wellness center, whose mission is to control and cure Crohn’s disease and colitis. The Roberts IBD Center can be linked to the hub of a wheel with other specialists (rheumatologist, radiologists, nutritionists, surgeons, nephrologists, endocrinologists) serving as the spokes. The Roberts IBD Center is dedicated to helping patients gain control of their disease, through:
• Effective therapies to control inflammation and restore quality of life
• Easy, convenient access to our multidisciplinary services and physicians
• Support and education
• Ongoing follow-up and health maintenance, bone and joint health, vaccination update, colon cancer screening, nutritional counseling
• Research and clinical trials for eligible patients
• Empowering patients to play an active role in improving their health

1315 York Ave.,Mezzanine Level
NewYork,NY10021
Tel.212.746.5077
Fax 212.746.8144

 Open Label Ustekinumab for the Treatment of Anti-TNFa Refractory Moderate-to-Severe Crohn’s Disease

 Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis

The purpose of this study is to evaluate the safety and effectiveness of trichuris suis ova (TSO) in ulcerative colitis (UC). We will look at how TSO affects the body's immune response and if there are related changes in participants' UC.

The cause of UC is not well understood. It is believed to be caused from an abnormal immune response to the normal bacteria that live in the gut (intestines and colon). This response acts as an "attack" on the healthy tissue of the bowel by a person's own immune cells which leads to disease.

It is well known that autoimmune diseases such as IBD, asthma, diabetes, and multiple sclerosis are more common in industrialized, well-developed countries with better sanitation and hygiene, as in the United States. These "cleaner" environments reduce exposure to germs and parasites naturally found in the environment. This reduced exposure may trigger responses in the body that make people more prone to diseases such as UC. People in non-industrialized countries and the tropics, where parasites are common, rarely develop these diseases. This observation has led researchers to want to better understand the relationship between the lack of natural bacteria in the gut and the onset of autoimmune diseases like as UC.

Estimated Enrollment: 120
Study Start Date: November 2013
Estimated Study Completion Date: September 2016
Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)